Clinical inclusion criteria (ocular and oral symptoms; ≥1 positive response to the following questions): 1) Have you had daily, persistent, troublesome dry eyes for >3 months? 2) Do you have a recurrent sensation of sand or gravel in your eyes? 3) Do you use tear substitutes >3 times a day? 4) Have you had a daily feeling of dry mouth for >3 months? 5) Do you frequently drink liquids to aid in swallowing dry food? Or suspicion of Sjögren syndrome based on ESSDAIa | |
Clinical exclusion criteria: History of head and neck radiation therapy, active HCV infection (confirmed by PCR), AIDS, sarcoidosis, amyloidosis, graft-versus-host disease, IgG4-related disease | |
Classification criteria (histopathology, autoantibodies, ocular signs) |
Points |
Diagnosis of focal lymphocytic sialadenitis in a labial salivary glandb with a focus score count >1 foci/4 mm2 |
3 |
Anti-Ro/SSA antibody positive |
3 |
Ocular staining scorec ≥5 or van Bijsterveld scored ≥4 in ≥1 eye |
1 |
Schirmer test ≤5 mm/5 minutes in ≥1 eyee |
1 |
Unstimulated whole saliva flow rate ≤0.1 mL/minf |
1 |
Interpretation: Patients with a total score ≥4 points meet the criteria for primary Sjögren syndrome (sensitivity, 96%; specificity, 95%) | |
a RMD Open. 2015;1(1):e000022. b Arthritis Rheum. 2011 Jul;63(7):2021-30. c Am J Ophthalmol. 2010 Mar;149(3):405-15. d Arch Ophthalmol. 1969 Jul;82(1):10-4. e Patients treated with anticholinergic drugs should be evaluated after a sufficient interval during which the drugs are withheld. | |
Adapted from Arthritis Rheumatol. 2017 Jan;69(1):35-45. | |
ACR, American College of Rheumatology; AIDS, acquired immunodeficiency syndrome; ESSDAI, EULAR Sjögren syndrome disease activity index; EULAR, European League Against Rheumatism; HCV, hepatitis C virus; PCR, polymerase chain reaction. |